CIM
ARNA

Cambria Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Cambria Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,160
Closed -$2.15M – 302
2021
Q4 		$2.15M Sell
23,160
-1,734
-7% -$114K 0.36% 122
2021
Q3 		$1.48M Buy
24,894
+7,551
+44% +$446K 0.27% 134
2021
Q2 		$1.18M Buy
17,343
+1,692
+11% +$110K 0.2% 143
2021
Q1 		$1.09M Buy
15,651
+4,653
+42% +$358K 0.22% 146
2020
Q4 		$845K Buy
10,998
+6,336
+136% +$475K 0.29% 79
2020
Q3 		$349K Buy
4,662
+888
+24% +$59.2K 0.13% 151
2020
Q2 		$238K Buy
+3,774
New +$208K 0.09% 158

Cambria Investment Management's ARNA Position: Q1 2022 in Review

Cambria Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 23,160 shares — an estimated $2.15M sold.

Cambria Investment Management first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $2.15M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Cambria Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Cambria Investment Management sold 23,160 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.15M.
  • Cambria Investment Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
  • Cambria Investment Management's Arena Pharmaceuticals Inc position peaked at $2.15M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Cambria Investment Management's 13F filing for Q1 2022, filed 16 May 2022.